These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
66 related items for PubMed ID: 8678538
1. [Effect of preoperative oral 5-fluorouracil on cell cycle of advanced cervical squamous cell carcinoma]. Kondoh H, Niwa K, Itoh N, Murase T, Morishita S, Imai A, Tamaya T. Gan To Kagaku Ryoho; 1996 Jun; 23(7):893-7. PubMed ID: 8678538 [Abstract] [Full Text] [Related]
2. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Yoshikawa R, Kusunoki M, Yanagi H, Noda M, Furuyama JI, Yamamura T, Hashimoto-Tamaoki T. Cancer Res; 2001 Feb 01; 61(3):1029-37. PubMed ID: 11221829 [Abstract] [Full Text] [Related]
3. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center. Athanasiadis I, Taylor S, Vokes EE, Pelzer HJ, Rademaker A, Mittal BB, Ganzenko N, Blough R, Lester EP, Kies MS. Cancer; 1997 Feb 01; 79(3):588-94. PubMed ID: 9028372 [Abstract] [Full Text] [Related]
4. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors. Kim YB, Cho JH, Keum KC, Lee CG, Seong J, Suh CO, Kim GE. Gynecol Oncol; 2007 Jan 01; 104(1):58-63. PubMed ID: 16919718 [Abstract] [Full Text] [Related]
5. First-line chemotherapy with 5-FU and platinum for advanced and recurrent cancer of the cervix: a phase II study. Ghaemmaghami F, Behtash N, Yarandi F, Moosavi A, Modares M, Toogeh G, Khanafshar N. J Obstet Gynaecol; 2003 Jul 01; 23(4):422-5. PubMed ID: 12881087 [Abstract] [Full Text] [Related]
6. [Neoadjuvant chemotherapy before radiotherapy in treatment of patients with cervical carcinoma]. Li QS, Zhang XQ, Li DP, Sheng XG, Du XL, Song QQ. Zhonghua Fu Chan Ke Za Zhi; 2006 Feb 01; 41(2):83-7. PubMed ID: 16640853 [Abstract] [Full Text] [Related]
7. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion. Huguet F, Cojocariu OM, Levy P, Lefranc JP, Darai E, Jannet D, Ansquer Y, Lhuillier PE, Benifla JL, Seince N, Touboul E. Int J Radiat Oncol Biol Phys; 2008 Dec 01; 72(5):1508-15. PubMed ID: 18676093 [Abstract] [Full Text] [Related]
8. [In vitro studies of 5-FU sensitivity on uterine cervical cancer cell lines--comparison between squamous cell carcinoma and adenocarcinoma]. Ueda M, Misaki O, Yamada T, Okamoto Y, Goto M, Maeda T, Okamura S, Ueki M, Sugimoto O. Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep 01; 41(9):1423-30. PubMed ID: 2531191 [Abstract] [Full Text] [Related]
9. [Clinical effects of concurrent chemoradiotherapy (hyperfractionation and cisplatin/5-fluorouracil) for patients with advanced oral squamous cell carcinoma]. Tsuchiya Y, Noguchi T, Matsumoto K, Matsumura T, Hoshi K, Ito H, Osano H, Jinbu Y, Kusama M. Gan To Kagaku Ryoho; 2009 Jan 01; 36(1):101-3. PubMed ID: 19151572 [Abstract] [Full Text] [Related]
10. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study. Rose PG, Blessing JA, Van Le L, Waggoner S. Gynecol Oncol; 1998 Aug 01; 70(2):263-6. PubMed ID: 9740702 [Abstract] [Full Text] [Related]
12. Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome. Ferrandina G, Macchia G, Legge F, Deodato F, Forni F, Digesù C, Carone V, Morganti AG, Scambia G. Oncology; 2008 Aug 01; 74(1-2):42-9. PubMed ID: 18544959 [Abstract] [Full Text] [Related]
13. [Enhanced induction of apoptosis of human colorectal cancer cells after preoperative treatment with 5-fluorouracil its relationship to DNA ploidy pattern]. Yamane N, Makino M, Taniguchi T, Kurayoshi K, Kaibara N. Gan To Kagaku Ryoho; 1998 Apr 01; 25 Suppl 3():404-9. PubMed ID: 9589043 [Abstract] [Full Text] [Related]
14. Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck. Baghi M, Hambek M, May A, Radeloff A, Gstoettner W, Knecht R. Anticancer Res; 2006 Apr 01; 26(1B):559-63. PubMed ID: 16739320 [Abstract] [Full Text] [Related]
15. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients. Ryu HS, Chun M, Chang KH, Chang HJ, Lee JP. Gynecol Oncol; 2005 Feb 01; 96(2):490-5. PubMed ID: 15661240 [Abstract] [Full Text] [Related]
16. Cervical cancer: combined modality therapy. Grigsby PW. Cancer J; 2001 Feb 01; 7 Suppl 1():S47-50. PubMed ID: 11504285 [Abstract] [Full Text] [Related]
17. Influence of stage classification, tumor differentiation and mode of invasion against clinical and histopathological effects on low dose sequential methotrexate and 5-fluorouracil administration as neo-adjuvant chemotherapy for oral squamous cell carcinoma. Asaumi J. In Vivo; 1997 Feb 01; 11(2):147-51. PubMed ID: 9179607 [Abstract] [Full Text] [Related]
18. Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer. Rodriguez-Pinilla M, Rodriguez-Peralto JL, Hitt R, Sanchez JJ, Ballestin C, Diez A, Sanchez-Verde L, Alameda F, Sanchez-Cespedes M. Clin Cancer Res; 2004 Dec 15; 10(24):8486-92. PubMed ID: 15623629 [Abstract] [Full Text] [Related]